SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-021233
Filing Date
2017-11-02
Accepted
2017-11-02 16:29:27
Documents
59
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10Q omed-10q_20170930.htm 10-Q 1527011
2 EX-10.1 - AMENDMENT 3 LONZA omed-ex101_189.htm EX-10.1 27344
3 EX-31.1 omed-ex311_8.htm EX-31.1 16529
4 EX-32.1 omed-ex321_6.htm EX-32.1 7054
  Complete submission text file 0001564590-17-021233.txt   5418344

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT omed-20170930.xml EX-101.INS 1226600
6 XBRL TAXONOMY EXTENSION SCHEMA omed-20170930.xsd EX-101.SCH 39286
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE omed-20170930_cal.xml EX-101.CAL 31274
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omed-20170930_def.xml EX-101.DEF 143828
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE omed-20170930_lab.xml EX-101.LAB 270731
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omed-20170930_pre.xml EX-101.PRE 242820
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35993 | Film No.: 171172812
SIC: 2834 Pharmaceutical Preparations